Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
Procter&Gamble Healt
|
Shilpa Medicare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
DMF Filingsby API
|
20.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.7 % | n/a | 3.76 % |
|
Financials
|
|||
|
5 yr Average ROE
|
7.64 % | 36.03 % | 3.68 % |
|
5yr average Equity Multiplier
|
3.58 | 1.79 | 1.62 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.77 | 0.37 |
|
5yr Avg Net Profit Margin
|
1.67 % | 19.19 % | 5.49 % |
|
Price to Book
|
2.64 | 13.67 | 3.51 |
|
P/E
|
26.12 | 28.86 | 57.09 |
|
5yr Avg Cash Conversion Cycle
|
41.09 Days | -155.74 Days | 92.76 Days |
|
Inventory Days
|
60.56 Days | 36.01 Days | 108.8 Days |
|
Days Receivable
|
71.09 Days | 40.92 Days | 118.16 Days |
|
Days Payable
|
82.93 Days | 215.28 Days | 123.42 Days |
|
5yr Average Interest Coverage Ratio
|
6.26 | 500.05 | 3.59 |
|
5yr Avg ROCE
|
6.7 % | 30.21 % | 5.94 % |
|
5yr Avg Operating Profit Margin
|
6.07 % | 27.53 % | 17.75 % |
|
5 yr average Debt to Equity
|
0.43 | 0.0 | 0.43 |
|
5yr CAGR Net Profit
|
22.48 % | 4.02 % | -11.93 % |
|
5yr Average Return on Assets
|
1.78 % | 15.5 % | 2.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 51.82 % | 40.13 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 8.73 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -9.88 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.77 % | 2.86 % | 5.15 % |
|
Akums Drugs & Pharma
|
Procter&Gamble Healt
|
Shilpa Medicare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|